Esther Troost
Esther Troost
Resident in Radiation Oncology
Adresse e-mail validée de
Citée par
Citée par
The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping
A Zwanenburg, M Vallières, MA Abdalah, HJWL Aerts, V Andrearczyk, ...
Radiology 295 (2), 328-338, 2020
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
RTH Leijenaar, G Nalbantov, S Carvalho, WJ Van Elmpt, EGC Troost, ...
Scientific reports 5 (1), 1-10, 2015
Rapid Learning health care in oncology’–an approach towards decision support systems enabling customised radiotherapy
P Lambin, E Roelofs, B Reymen, ER Velazquez, J Buijsen, CML Zegers, ...
Radiotherapy and Oncology 109 (1), 159-164, 2013
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
S Leger, A Zwanenburg, K Pilz, F Lohaus, A Linge, K Zöphel, J Kotzerke, ...
Scientific reports 7 (1), 1-11, 2017
18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors
EGC Troost, J Bussink, AL Hoffmann, OC Boerman, WJG Oyen, ...
Journal of Nuclear Medicine 51 (6), 866-874, 2010
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients
EGC Troost, WV Vogel, MAW Merkx, PJ Slootweg, HAM Marres, ...
Journal of nuclear medicine 48 (5), 726-735, 2007
18F-FDG PET early response evaluation of locally advanced non–small cell lung cancer treated with concomitant chemoradiotherapy
EA Usmanij, LF de Geus-Oei, EGC Troost, L Peters-Bax, ...
Journal of Nuclear Medicine 54 (9), 1528-1534, 2013
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome
BAW Hoeben, EGC Troost, PN Span, CML van Herpen, J Bussink, ...
Journal of Nuclear Medicine 54 (4), 532-540, 2013
PET of hypoxia with 89Zr-labeled cG250-F (ab′) 2 in head and neck tumors
BAW Hoeben, JHAM Kaanders, GM Franssen, EGC Troost, PFJW Rijken, ...
Journal of Nuclear Medicine 51 (7), 1076-1083, 2010
Clinical evidence on PET–CT for radiation therapy planning in head and neck tumours
EGC Troost, DAX Schinagl, J Bussink, WJG Oyen, JHAM Kaanders
Radiotherapy and Oncology 96 (3), 328-334, 2010
Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging
S Löck, R Perrin, A Seidlitz, A Bandurska-Luque, S Zschaeck, K Zöphel, ...
Radiotherapy and Oncology 124 (3), 533-540, 2017
Assessing robustness of radiomic features by image perturbation
A Zwanenburg, S Leger, L Agolli, K Pilz, EGC Troost, C Richter, S Löck
Scientific reports 9 (1), 1-10, 2019
Relative biological effectiveness in proton beam therapy–Current knowledge and future challenges
A Lühr, C von Neubeck, M Krause, EGC Troost
Clinical and translational radiation oncology 9, 35-41, 2018
Correlation of [18F] FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts
EGC Troost, P Laverman, MEP Philippens, J Lok, AJ van der Kogel, ...
European journal of nuclear medicine and molecular imaging 35 (10), 1803-1811, 2008
In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F] HX4 and [18F] FDG-PET/CT ImagingHypoxic and Metabolic Status of NSCLC Using HX4 and FDG-PET/CT
CML Zegers, W Van Elmpt, B Reymen, AJG Even, EGC Troost, MC Öllers, ...
Clinical Cancer Research 20 (24), 6389-6397, 2014
Radiotherapy Combined with the Immunocytokine L19-IL2 Provides Long-lasting Antitumor EffectsRadiotherapy in Combination with the Immunocytokine L19-IL2
CML Zegers, NH Rekers, DHF Quaden, NG Lieuwes, A Yaromina, ...
Clinical cancer research 21 (5), 1151-1160, 2015
Imaging hypoxia after oxygenation-modification: comparing [18F] FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors
EGC Troost, P Laverman, JHAM Kaanders, M Philippens, J Lok, ...
Radiotherapy and Oncology 80 (2), 157-164, 2006
Hypoxia imaging with [18F] HX4 PET in NSCLC patients: defining optimal imaging parameters
CML Zegers, W van Elmpt, R Wierts, B Reymen, H Sharifi, MC Öllers, ...
Radiotherapy and Oncology 109 (1), 58-64, 2013
PET in the management of locally advanced and metastatic NSCLC
W Grootjans, LF de Geus-Oei, EGC Troost, EP Visser, WJG Oyen, ...
Nature reviews Clinical oncology 12 (7), 395-407, 2015
Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus
M Lambrecht, DBP Eekers, C Alapetite, NG Burnet, V Calugaru, ...
Radiotherapy and Oncology 128 (1), 26-36, 2018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20